Almonty's Board Gets Two New Faces as Analysts Trim Targets and Sangdong Finds Its Footing
Published on 11/19/2026 at 22:10 | Editorial boerse-global.deAlmonty Industries used a single Tuesday announcement to do two things at once: seat two independent directors and declare its intention to pursue a secondary listing on the Korea Exchange. Only the first is done. The second still needs approval, a distinction worth keeping in mind as the tungsten producer's story shifts from boardroom housekeeping to the harder work of turning first production into steady shipments.
Eugene Bae and Jim Rudyk — James Rudyk in the company's own wording — join the board as independent members. David Hanick and Andrew Frazer are set to leave as of December 31, 2026. The appointments are a settled matter; the Korean venue is not.
The stock slipped 2.8% to €6.90 on Thursday evening, extending a 30-day decline of 13%.
Analysts Move, Each for Their Own Reasons
Two research houses cut their price targets within days of each other, though the signals differ. Sphene Capital lowered its target on Monday to US$22.40 from US$26.40 while keeping its buy rating intact. B. Riley Securities trimmed its own target on Tuesday to US$18 from US$20, also without touching its recommendation. A lower target and an unchanged rating are separate statements: one marks down the expected level, the other leaves the verdict alone.
Should investors sell immediately? Or is it worth buying Almonty?
Diamond Equity Research took a different route on Tuesday, revising its tungsten price assumptions and its timeline for the Sangdong operation. Citing a slower ramp-up and later deliveries, the firm cut its fourth-quarter 2026 earnings-per-share estimate to $0.04 from $0.14. That figure is an estimate, not a reported result — and its provenance matters. Diamond Equity disclosed that Almonty had paid it US$100,000 for sponsored research services, so what carries weight is which assumptions moved: delivery timing and the tungsten price are both part of the calculation.
A Quarter Flattered by Paper Gains
The operating backdrop is improving, at least on the top line. Revenue in the third quarter of 2026 climbed 382% year over year to C$41.9 million. Net profit reached C$50.2 million, up 51% from the prior-year quarter — but that result included C$47.9 million in non-cash revaluation gains, a reminder that the headline number owes most of its weight to accounting marks rather than the mine.
Sangdong itself hit a genuine milestone in September, producing tungsten concentrate for the first time. The first container was loaded for shipment after the quarter closed, and more than 90% of output from the project's first phase was already contractually committed, according to the company. A loaded container is concrete progress; whether it becomes a reliable delivery operation is a separate question, and one the analysts above are clearly still weighing.
Canada: A Claim, Not a Verdict
A third thread runs alongside the listing plans and the ramp-up. Deutsche Rohstoff AG said in its quarterly report on Tuesday that the Canadian proceedings between the parties have been consolidated. Almonty has filed claims of its own against Deutsche Rohstoff. Consolidation affects procedure, not the outcome of the claims themselves.
Deutsche Rohstoff puts its claim at roughly US$67 million, centered on conversion rights and outstanding loans. That sum is the amount asserted — not a fixed payment obligation on Almonty's part, and not a prediction of how the case will end.
Read together, the board appointments are a finished decision, the Korean listing remains subject to approval, Sangdong's next shipments are the real gauge of the ramp-up, and Canada will be settled on the merits. Those distinctions say more about Almonty's progress than the simple count of its ambitions.
Ad
Almonty Stock: New Analysis - 19 November
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
